NCT06190561View on ClinicalTrials.gov

A Study to Learn How Different Products of the Study Medicine Called PF-07940367 Are Taken up Into the Blood in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 15, 2024

Primary Completion Date

May 7, 2024

Study Completion Date

May 7, 2024

Conditions
Healthy
Interventions
DRUG

PF-07940367

Participants to receive a single dose of PF-07940367 product II 150 mg by mouth

DRUG

PF-07940367

Participants to receive a single dose of PF-07940367 product I 150 mg by mouth

Trial Locations (1)

92801

Anaheim Clinical Trials, LLC, Anaheim

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT06190561 - A Study to Learn How Different Products of the Study Medicine Called PF-07940367 Are Taken up Into the Blood in Healthy Adults | Biotech Hunter | Biotech Hunter